Posted by Alan on October 10, 2002, at 18:32:22
In reply to Re: AD's vs. Bzds for Anxiety disorders » Alan, posted by pharmrep on October 9, 2002, at 22:22:18
> ************** what i say is not "company" oriented...just from me. I give a "source" to lend credibility...so as not to be just my opinion. (after all, i did openly identify myself as pharmrep)
> > ============================================
> >
> > I guess that pharmrep is choosing not to answer some very important questions about AD's vis-a-vis their use in treatment of symptoms for anxiety disorders.
> >
> > One would think that a pharmecutical representative would be more than willing to answer these fundamental questions for a very large population of us anxiety sufferers that tried ssri's for many years only to end up on the basic anxiolytic anyway - the lowly benzodiazapine. Or had to augment an ssri with a bzd in the end ....
> >
> > Is that because there are really no legitimate medical answers as to why AD's are presently being promoted as the first line of treatment for the disorder - and not on equal footing with the Benzodiazapines???
> >
> > Why is all of the evidence that the most effective and safe anxiolytic known to medicine - the bzd - brushed aside by the promoting of new AD's in their place rather than along side with the benzodiazapine to give the doctor and patient alike the freedom to choose? Otherwise, isn't freedom being taken away?
> >
> > Would it have anything to do with putting profit before medicine to regain R & D and marketshare?
> >
> > Not meant as just rhetorical questions. Sincerely and honestly wondering...
> >
> > Alan
> >
>
> *** come on alan..if the pharm industry wanted to make money in bzds vs ad's it probably could...it just chooses to focus on ad's because there is more to work with, and more people to aim for...and i believe a proven track record for effectiveness...and why are you attacking me about it? I am here to help not hurt..so be civil=================================================
I'm not attacking you. I'm asking legitimate questions from a pharmecutical authority about specifically why AD's are being pushed in place of BZD's in the treatment of anxiety disorders, that's all.I don't believe the anwers that you are providing are as clearly spelled out for us in the same way that you spell out specifics regarding the single merits of AD's - specifically Lexapro. Certainly the efficacy rates, if they are to be taken at face value, aren't even close to the rates of BZD's.
It's a legitimate question that is important to be addressed for all of us...and I believe that I've asked civily and sincerely several times now.
If you're not sure, an "I'm not sure" will do.
Alan
poster:Alan
thread:109458
URL: http://www.dr-bob.org/babble/20021006/msgs/123112.html